The ITC as an attractive patent litigation forum for the biotechnology and pharmaceutical industry

By Burton Carlyn A   Margonis Lisa E  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. : 177-180

Future Science

Access to resources Recommend Favorite

Preliminary injunctions in generic and branded patent litigation

By Cohen Simon   England Paul  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 9, 2013-09 ,pp. : 1083-1086

Informa Healthcare

Access to resources Recommend Favorite

Developing trends in pharmaceutical patent claims

By Cook T.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 635-643

Informa Healthcare

Access to resources Recommend Favorite

Different rules, different results: patent litigation after In re Baxter

By Vogel Bryan J   Roberg-Perez Sharon E  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 3, 2013-05 ,pp. : 295-297

Future Science

Access to resources Recommend Favorite

The Community Patent: What This Means for the Pharmaceutical Industry

By Cohen L.J.  

Pharmaceutical Development and Regulation, Vol. 1, Iss. 1, 2003-01 ,pp. : 3-10

Adis International

Access to resources Recommend Favorite